You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 6,974,578


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,974,578
Title: Method for treating secretions and glands using botulinum toxin
Abstract:Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of, Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s): Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:08/627,118
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

United States Patent 6,974,578: A Comprehensive and Critical Analysis

Introduction

United States Patent 6,974,578, though not directly provided in the sources, can be analyzed within the context of patent law and the broader patent landscape. This analysis will cover key aspects of patent claims, the patent application process, and relevant legal doctrines that impact the validity and enforceability of patents.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For a patent like 6,974,578, the claims must meet the fundamental requirements of patentability: originality, novelty, utility, and nonobviousness[3].

Patentability Requirements

  • Originality: The invention must be the work of the inventor, not derived from others without permission.
  • Novelty: The invention must be new and not obvious to others in the field.
  • Utility: The invention must have a practical application or be capable of being used for a specific purpose.
  • Nonobviousness: The invention must be significantly different from existing technology and not obvious to a person of ordinary skill in the relevant field[3].

The Patent Application Process

The process of obtaining a patent involves several steps, including filing, examination, and potential appeals. Here’s an overview:

Filing the Patent Application

The applicant must submit a detailed description of the invention, including drawings and claims. The application must be filed with the United States Patent and Trademark Office (USPTO)[4].

Examination

The USPTO examines the application to ensure it meets the requirements of patentability. This includes a search for prior art to determine novelty and nonobviousness[4].

Prosecution and Appeals

During prosecution, the applicant may need to respond to office actions, amend claims, or argue against rejections. If the application is rejected, the applicant can appeal to the Patent Trial and Appeal Board (PTAB) or the Federal Circuit[3].

Double Patenting and Terminal Disclaimers

Double patenting, particularly obviousness-type double patenting (ODP), is a critical issue. ODP prevents the granting of a subsequent patent that is an obvious modification of an earlier granted patent. To avoid this, applicants must file a terminal disclaimer to disclaim any term in the second or further patent application that would extend the term of already-issued patents[2].

Patent Term Adjustments (PTA) and Obviousness-Type Double Patenting

PTA compensates applicants for delays caused by the USPTO during prosecution, extending the patent term up to three years. However, as seen in the In re Cellect case, PTA can interact with ODP in complex ways. If PTA results in a later-expiring claim that is patentably indistinct from an earlier patent, the claims may be invalid due to ODP[2].

The Role of AI in Patent Applications

With the increasing use of AI tools in drafting patent applications, there is a need for transparency. If an AI tool significantly contributes to the invention, this must be disclosed to the USPTO to ensure the named inventors have indeed contributed to the claimed invention[5].

Global Patent Landscape and Prior Art

The global patent landscape is interconnected, with tools like the Global Dossier providing access to file histories of related applications from participating IP offices. This helps in identifying prior art and ensuring that the invention is novel and nonobvious on a global scale[4].

Legal Doctrines and Case Law

Chisum on Patents

Donald S. Chisum's treatise is a comprehensive resource on patent law, covering doctrines, rules, and case law. It provides detailed analysis on patentability, validity, and infringement, including recent decisions that impact patent claims[3].

Federal Circuit Decisions

Decisions from the Federal Circuit, such as In re Cellect, provide important insights into the interaction between PTA and ODP. These decisions emphasize the importance of terminal disclaimers and the need for patent owners to be vigilant about ODP concerns[2].

Patent Search and Public Access

The USPTO provides several tools for searching patents, including the Patent Public Search tool and the Public Search Facility. These resources help in conducting thorough prior art searches and understanding the existing patent landscape[4].

Key Takeaways

  • Patent Claims: Must meet the requirements of originality, novelty, utility, and nonobviousness.
  • Double Patenting: Terminal disclaimers are crucial to avoid ODP issues.
  • PTA and ODP: PTA can lead to invalid claims if it results in patentably indistinct claims.
  • AI in Patent Applications: Disclosure of AI contributions is necessary to ensure inventorship.
  • Global Patent Landscape: Prior art searches must be global to ensure novelty and nonobviousness.
  • Legal Doctrines: Understanding recent case law and doctrines is essential for navigating the patent landscape.

Frequently Asked Questions

What are the fundamental requirements for patentability?

The fundamental requirements for patentability are originality, novelty, utility, and nonobviousness[3].

How does obviousness-type double patenting impact patent claims?

ODP prevents the granting of a subsequent patent that is an obvious modification of an earlier granted patent. This can be mitigated by filing a terminal disclaimer[2].

What is the role of AI in patent applications?

AI tools can assist in drafting patent applications, but any significant contributions must be disclosed to the USPTO to ensure proper inventorship[5].

How can one conduct a thorough prior art search?

Using tools like the Patent Public Search, Global Dossier, and the Public Search Facility can help in conducting a thorough prior art search[4].

What is the significance of terminal disclaimers in patent applications?

Terminal disclaimers are essential to avoid ODP issues by disclaiming any term that would extend the term of already-issued patents[2].

Cited Sources

  1. United States Patent 8,133,497 B2 - Methods and apparatus for delivery of a therapeutic agent.
  2. Federal Circuit Puts the Onus on Patent Owners to Disclaim - Mintz.
  3. Chisum on Patents - LexisNexis Store.
  4. Search for patents - USPTO.
  5. U.S. Patent Office Issues Additional Guidance on Use of AI Tools - Buchanan Ingersoll & Rooney PC.

More… ↓

⤷  Subscribe

Details for Patent 6,974,578

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 6,974,578 2013-12-28
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 6,974,578 2013-12-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.